Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Net Margin (2020 - 2025)

Historic Net Margin for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to 32.35%.

  • RxSight's Net Margin fell 144100.0% to 32.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 25.15%, marking a year-over-year decrease of 12200.0%. This contributed to the annual value of 19.62% for FY2024, which is 349500.0% up from last year.
  • As of Q3 2025, RxSight's Net Margin stood at 32.35%, which was down 144100.0% from 35.04% recorded in Q2 2025.
  • In the past 5 years, RxSight's Net Margin registered a high of 14.77% during Q4 2024, and its lowest value of 300.0% during Q2 2021.
  • Over the past 5 years, RxSight's median Net Margin value was 66.33% (recorded in 2023), while the average stood at 98.71%.
  • Within the past 5 years, the most significant YoY rise in RxSight's Net Margin was 3274600bps (2021), while the steepest drop was -3605200bps (2021).
  • Over the past 5 years, RxSight's Net Margin (Quarter) stood at 186.73% in 2021, then soared by 48bps to 97.05% in 2022, then surged by 67bps to 32.12% in 2023, then soared by 54bps to 14.77% in 2024, then crashed by -119bps to 32.35% in 2025.
  • Its Net Margin stands at 32.35% for Q3 2025, versus 35.04% for Q2 2025 and 21.61% for Q1 2025.